Healthcare
As one of the US’ largest and most consumer-driven industries, healthcare is poised for significant M&A activity and investments. From consolidation within fragmented sub-sectors to “capabilities building” to improve quality of care and reduce costs throughout the industry, healthcare doubtless will remain exceptionally dynamic in all respects for the foreseeable future.
The McLean Group’s Healthcare team supports middle market healthcare companies by leveraging exceptional expertise in mergers and acquisitions and capital formation services. From identifying suitable acquisition targets to augment organic growth or build strategic capabilities, to providing advice on how to maximize the value owners realize when selling their businesses, to raising capital from private institutional sources to scale up operations, our Healthcare practice is committed to helping clients achieve their specific goals.
Our Healthcare team focuses on the following industry sectors:
-
Healthcare Information Technology
-
Life Sciences
-
Medical Devices
-
Medical Supplies and Distribution
-
Other Healthcare Services
Our Healthcare team professionals' wealth of transaction, capital markets and industry-specific experience enables us to help clients implement their M&A strategies. Clients include:
| - 3M Health Care | - Eli Lilly & Company |
|
| - Abbott Laboratories | - Genesis Eldercare | |
| - Blue Cross-Blue Shield of Maryland | - Hillenbrand Industries, Inc. |
|
| - Bristol-Myers Squibb | - J&J Life Technologies | |
| - Caremark, Inc. | - Penwest Pharmaceuticals Co. |
|
| - CIGNA | - Pioneer Life Insurance Company |
|
| - CNA Insurance | - Reynolds & Reynolds Co. | |
| - CUNA Mutual Group |
- Shared Medical Systems Corp. |
|
| - Delta Dental Insurance |
We are committed to providing our healthcare clients expert M&A advice and capital access ideas and solutions.
To view practice leaders click here.
Representative Engagements:
 |
 |
 |
 |